Divya Shah

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, Joe Grove, Oscar A. MacLean et al. · Nature Microbiology · 2022 · 701 citations · Full text

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial

Cornelia L. Trimble, Matthew P. Morrow, Kimberly A. Kraynyak et al. · The Lancet · 2015 · 689 citations

Immunology, Human Papillomavirus 16, Cancer-associated Virus +17

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa et al. · Cell Reports · 2021 · 446 citations · Full text

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 391 citations · Full text

Long Covid, Treatment And Prevention, Covid-19 Pandemic +9

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

Holly LaDuca, Aaron J. Stuenkel, Jill S. Dolinsky et al. · Genetics in Medicine · 2014 · 335 citations · Full text